Mike Stedman

University of Manchester

H指数:17

被引数:1,353

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Incidence and risk factors for chronic kidney disease in individuals with type 1 diabetes: A population-based study in Salford, Manchester

1型糖尿病个体中慢性肾脏病的发病率和危险因素：一项在曼彻斯特萨尔福德地区进行的人群研究

DIABETIC MEDICINE

IF3.4

2025-11-010

OAAI

The impact of an online self-management programme for type 2 diabetes. The BEATdiabetes prospective service evaluation

2型糖尿病在线自我管理项目的影响。BEATdiabetes前瞻性服务评估

Primary Care Diabetes

IF2.3

2025-10-270

PRE

Risk of Death and Adverse Effects in Patients on Liothyronine: A Multisource Systematic Review and Meta-analysis

左甲状腺素钠治疗患者的死亡风险和不良反应：一项多源系统评价和荟萃分析

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

IF5.1

2025-08-011

The Influence of Local Service Configuration on All-Cause Mortality: An Age- and Sex-Standardised Analysis

本地服务配置对全因死亡率的影响：一项按年龄和性别标准化的分析

Primary Care Diabetes

IF2.3

2025-07-150

OAAI

Improving Diabetes Monitoring in People with Sub-optimally Controlled Diabetes: Implementing a Clinical Laboratory-Led Quality Improvement Initiative in General Practice

改善糖尿病监测：在基层医疗中实施临床实验室主导的质量改进倡议，针对控制欠佳的糖尿病患者

Diabetes Therapy

IF2.6

2025-07-090

OAAI

Consistency of the personalized glycated haemoglobin (pHbA1c) methodology over time in people with type 1 diabetes (T1D) using continuous glucose monitoring

DIABETIC MEDICINE

IF3.4

2025-02-030

OAAI

The influence of ethnicity and social disadvantage on frailty in a United Kingdom (UK) population

AGE AND AGEING

IF7.1

2025-01-300

PRE

How Does Thyroid Hormone Profile Differ on and Off Replacement Treatment?

CLINICAL ENDOCRINOLOGY

IF2.4

2024-12-190

Liothyronine (LT3) prescribing in England: Are cost constraints inhibiting guideline implementation?

CLINICAL ENDOCRINOLOGY

IF2.4

2024-05-160

Mortality in people with a diabetes foot ulcer: An update from the Salford podiatry clinic follow-up study

DIABETIC MEDICINE

IF3.4

2024-04-091

Changes in prescribing of psychotropic vs some physical health medication in primary care through the COVID-19 pandemic in England: a national-level survey

JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE

IF2.5

2024-03-114

OAAI

Counting the lifetime cost of obesity: Analysis based on national England data

DIABETES OBESITY & METABOLISM

IF5.7

2024-02-054

Natural desiccated thyroid for the treatment of hypothyroidism?

自然干燥甲状腺治疗甲状腺功能减退症？

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2024-01-083

OAAI

Liothyronine prescribing in England: costs versus need

LANCET

IF88.5

2023-12-010

OAAI

Diabetes foot complications and standardized mortality rate in type 2 diabetes

DIABETES OBESITY & METABOLISM

IF5.7

2023-09-188

The change in glycaemic control immediately after the 3rd COVID-19 vaccination in people with type 1 diabetes

DIABETIC MEDICINE

IF3.4

2023-05-170

Variability in Test Interval Is Linked to Glycated Haemoglobin (HbA1c) Trajectory over Time

JOURNAL OF DIABETES RESEARCH

IF3.4

2022-05-163

OAAI

Analysis of Continuous Blood Glucose Data in People with Type 1 Diabetes (T1DM) After COVID-19 Vaccination Indicates a Possible Link Between the Immune and the Metabolic Response

JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY

IF3.7

2021-07-2914

OAAI

The links between the amount of antipsychotic medication prescribed at GP practice level, local demographic factors and medication selection

BJPSYCH OPEN

IF3.5

2021-06-180

OAAI

Reducing fatigue-related symptoms in Long COVID-19: finding an intervention that works

BJPSYCH OPEN

IF3.5

2021-06-180

OAAI

Mike Stedman

个人简介

教育背景

工作经历

荣誉奖项

研究方向